| Issue Date | Title | Author(s) |
| 2021 | A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice | Chaprov, K.; Rezvykh, A.; Funikov, S.; Ivanova, T. A.; Deykin, A. V. |
| 2023 | Association between HSPA8 Gene Variants and Ischemic Stroke: A Pilot Study Providing Additional Evidence for the Role of Heat Shock Proteins in Disease Pathogenesis | Kobzeva, K. A.; Soldatova, M. O.; Soldatov, V. O.; Deykin, A. V.; Churnosov, M. I. |
| 2022 | Cytokines in abdominal aortic aneurysm: master regulators with clinical application | Puchenkova, O. A.; Soldatov, V. O.; Deykin, A. V.; Korokin, M. V.; Pokrovskiy, M. V. |
| 2021 | Genetically modified animals for use in bio‑pharmacology: from research to production | Deykin, A. V.; Shcheblykina, O. V.; Povetka, E. E.; Golubinskaya, P. A.; Pokrovsky, V. M. |
| 2020 | On the way from SARS-CoV-sensitive mice to murine COVID-19 model | Soldatov, V. O.; Kubekina, M. V.; Silaeva, Yu. Yu.; Bruter, A. V.; Deykin, A. V. |
| 2021 | Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] gene | Soldatov, V. O.; Kukharsky, M. S.; Puchenkova, O. A.; Deykin, A. V.; Pokrovskiy, M. V. |
| 2021 | Retinal damage in amyotrophic lateral sclerosis: underlying mechanisms | Soldatov, V. O.; Kukharsky, M. S.; Belykh, A. E.; Sobolev, A. M.; Deykin, A. V. |
| 2022 | The tissue distribution of SARS-CoV-2 in transgenic mice with inducible ubiquitous expression of hACE2 | Dolskiy, A. A.; Gudymo, A. S.; Taranov, O. S.; Soldatov, V. O.; Deykin, A. V. |
